Page last updated: 2024-10-31

methylphenidate and Asphyxia Neonatorum

methylphenidate has been researched along with Asphyxia Neonatorum in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Asphyxia Neonatorum: Respiratory failure in the newborn. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HOAGLAND, RJ1

Other Studies

1 other study available for methylphenidate and Asphyxia Neonatorum

ArticleYear
PHARMACOLOGIC TREATMENT OF COMA OF DIVERSE ORIGIN.
    The American journal of the medical sciences, 1965, Volume: 249

    Topics: Acidosis; Antitoxins; Asphyxia Neonatorum; Cerebral Hemorrhage; Coma; Craniocerebral Trauma; Diabeti

1965